关注
EVANTHIA DIAMANTI-KANDARAKIS
EVANTHIA DIAMANTI-KANDARAKIS
National and Kapodistrian University of Athens, Emeritus Professor of Endocrinology
在 med.uoa.gr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Endocrine-disrupting chemicals: an Endocrine Society scientific statement
E Diamanti-Kandarakis, JP Bourguignon, LC Giudice, R Hauser, GS Prins, ...
Endocrine reviews 30 (4), 293-342, 2009
51652009
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
R Azziz, E Carmina, D Dewailly, E Diamanti-Kandarakis, ...
Fertility and sterility 91 (2), 456-488, 2009
24192009
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline
R Azziz, E Carmina, D Dewailly, E Diamanti-Kandarakis, ...
The Journal of Clinical Endocrinology & Metabolism 91 (11), 4237-4245, 2006
23152006
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications
E Diamanti-Kandarakis, A Dunaif
Endocrine reviews 33 (6), 981-1030, 2012
19672012
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile
E Diamanti-Kandarakis, CR Kouli, AT Bergiele, FA Filandra, TC Tsianateli, ...
The journal of clinical endocrinology & metabolism 84 (11), 4006-4011, 1999
15641999
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and …
RA Wild, E Carmina, E Diamanti-Kandarakis, A Dokras, ...
The Journal of Clinical Endocrinology & Metabolism 95 (5), 2038-2049, 2010
12692010
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
G Conway, D Dewailly, E Diamanti-Kandarakis, HF Escobar-Morreale, ...
European journal of endocrinology 171 (4), P1-P29, 2014
9172014
Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary …
R Azziz, E Carmina, D Dewailly, E Diamanti-Kandarakis, ...
Fertil Steril 91 (2), 456-488, 2009
5122009
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
A Dunaif, X Wu, A Lee, E Diamanti-Kandarakis
American Journal of Physiology-Endocrinology and Metabolism 281 (2), E392-E399, 2001
5092001
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS
E Kandaraki, A Chatzigeorgiou, S Livadas, E Palioura, F Economou, ...
The Journal of Clinical Endocrinology & Metabolism 96 (3), E480-E484, 2011
4992011
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
E Diamanti-Kandarakis, C Kouli, T Tsianateli, A Bergiele
European Journal of Endocrinology 138 (3), 269-274, 1998
4951998
Exercise and the stress system
G Mastorakos, M Pavlatou, E Diamanti-Kandarakis, GP Chrousos
Hormones (Athens) 4 (2), 73-89, 2005
4712005
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
E Diamanti-Kandarakis, AG Papavassiliou
Trends in molecular medicine 12 (7), 324-332, 2006
4582006
Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline
R Azziz, E Carmina, D Dewailly, E Diamanti-Kandarakis, ...
J Clin Endocrinol Metab 91 (11), 4237-4245, 2006
4362006
Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
MG Hayes, M Urbanek, DA Ehrmann, LL Armstrong, JY Lee, R Sisk, ...
Nature communications 6 (1), 7502, 2015
3832015
Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy
E Diamanti-Kandarakis, G Spina, C Kouli, I Migdalis
The Journal of Clinical Endocrinology & Metabolism 86 (10), 4666-4673, 2001
3722001
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
E Diamanti-Kandarakis, CD Christakou, E Kandaraki, FN Economou
European journal of endocrinology 162 (2), 193-212, 2010
3642010
Pathophysiology and types of dyslipidemia in PCOS
E Diamanti-Kandarakis, AG Papavassiliou, SA Kandarakis, GP Chrousos
Trends in Endocrinology & Metabolism 18 (7), 280-285, 2007
3642007
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
E Diamanti-Kandarakis
Expert Reviews in molecular medicine 10, e3, 2008
3592008
The role of genes and environment in the etiology of PCOS
E Diamanti-Kandarakis, H Kandarakis, RS Legro
Endocrine 30, 19-26, 2006
3342006
系统目前无法执行此操作,请稍后再试。
文章 1–20